Involved-field radiation therapy for locoregionally recurrent ovarian cancer

Gynecologic Oncology

Volumn 130, Issue 2, 2013, Pages 300-305

  Brown, Aaron P ^a   Jhingran, Anuja ^a   Klopp, Ann H ^a   Schmeler, Kathleen M ^a   Ramirez, Pedro T ^a   Eifel, Patricia J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Ovarian cancer Radiation therapy Clear cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM DERIVATIVE;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DISEASE FREE INTERVAL; FEMALE; FOLLOW UP; HUMAN; INVOLVED FIELD RADIATION THERAPY; LAPAROTOMY; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; OVARY CARCINOMA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE RISK; SALPINGOOOPHORECTOMY;

CLEAR CELL CARCINOMA; OVARIAN CANCER; RADIATION THERAPY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84880311122     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.04.469     Document Type: Article

References (22)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 Cancer 62 2012 10 29
2. T.J. Herzog, and B. Pothuri Ovarian cancer: a focus on management of recurrent disease Nat Clin Pract Oncol 3 2006 604 611
3. S.A. Cannistra Cancer of the ovary N Engl J Med 351 2004 2519 2529
4. G.M. Thomas, and A.J. Dembo Integrating radiation therapy into the management of ovarian cancer Cancer 71 1993 1710 1718
5. G.M. Thomas Radiotherapy in early ovarian cancer Gynecol Oncol 55 1994 1541 1546
6. A. Fyles, G. Bolis, C. Ferraris, M. Bolla, and F. Parazzini Is abdomino-pelvic radiation therapy the optimal treatment for completely resected stage I and II high risk ovarian cancer? Eur J Cancer 33 1997 12 19
7. H. Cardenes, and M.E. Randall Integrating radiation therapy in the curative management of ovarian cancer: current issues and future directions Semin Radiat Oncol 10 2000 61 70
8. Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia Int J Gynecol Obstet 105 2009 3 4
9. K.V. Albuquerque, R. Singla, R.K. Potkul, D.M. Smith, S. Creech, and S. Lo Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancer Gynecol Oncol 96 2005 701 704
10. K. Fujiwara, S. Suzuki, E. Yoden, H. Ishikawa, Y. Imajo, and I. Kohno Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapy Int J Gynecol Cancer 12 2002 250 256
11. S. Davidson, S. Rubin, B. Mychalczak, P.E. Saigo, J.L. Lewis, and D. Chapman Limited-field radiotherapy as salvage treatment of localized persistent or recurrent epithelial ovarian cancer Gynecol Oncol 51 1993 349 354
12. S.W. Lee, S.M. Park, Y.M. Kim, Y.S. Kim, E.K. Choi, and D.Y. Kim Radiation therapy is a treatment to be considered for recurrent epithelial ovarian cancer after chemotherapy Tumori 97 2011 590 595
13. K. Yahara, T. Ohguri, H. Imada, S. Moon, S. Yamaguchi, and H. Narisada Epithelial ovarian cancer: definitive radiotherapy for limited recurrence after complete remission [Abstract] ASTRO Annual Meeting 2011
14. L.J. Lee, C. Newhouse, Y. Chen, and A. Viswanathan Nonserous histology and platinum-sensitivity are prognostic in localized recurrent ovarian cancer treated with radiation therapy [Abstract] ASTRO Annual Meeting 2012
15. R.E. Bristow, I. Puri, and D.S. Chi Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis Gynecol Oncol 112 2009 265 274
16. Y.Y. Lee, T.J. Kim, M.J. Kim, H.J. Kim, T. Song, and M.K. Kim Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis Gynecol Oncol 122 2011 541 547
17. M.G. del Carmen, M. Birrer, and J.O. Schorge Clear cell carcinoma of the ovary: a review of the literature Gynecol Oncol 126 2012 481 490
18. R. Salani, A. Santillan, M.L. Zahurak, R.L. Giuntoli, G.J. Gardner, and D.K. Armstrong Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome Cancer 15 109 2007 685 691
19. D.S. Chi, K. McCaughty, J.P. Diaz, J. Huh, S. Schwabenbauer, and A.J. Hummer Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma Cancer 1 106 2006 1933 1939
20. R.Y. Zang, Z.T. Li, J. Tang, X. Cheng, S.M. Cai, and Z.Y. Zhang Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits? Cancer 100 2004 1152 1161
21. S.J. Tebes, R.A. Sayer, J.M. Palmer, C.C. Tebes, M.A. Martino, and M.S. Hoffman Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma Gynecol Oncol 106 2007 482 487
22. T.L. Cannon, D.W. Lai, D. Hirsch, M. Delacure, A. Downey, and A.R. Kerr Squamous cell carcinoma of the oral cavity in nonsmoking women: a new and unusual complication of chemotherapy for recurrent ovarian cancer? Oncologist 17 2012